Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
trodusquemine protein-tyrosine phosphatase 1b NA Clinical trial target TTD , DGIDB Obesity[MeSHID:D009765]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of breast[MeSHID:D001943]		 3.98 phase 1 inhibitor
trodusquemine tyrosine-protein phosphatase non-receptor type 1 small molecule NA drugbank , DGIDB Obesity[MeSHID:D009765]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of breast[MeSHID:D001943]		 3.98 investigational unknown
trodusquemine tyrosine-protein phosphatase non-receptor type 1 small molecule NA drugbank , DGIDB Obesity[MeSHID:D009765]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of breast[MeSHID:D001943]		 3.98 investigational inhibitor
trodusquemine protein-tyrosine phosphatase 1b NA Clinical trial target TTD , DGIDB Obesity[MeSHID:D009765]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of breast[MeSHID:D001943]		 3.98 phase 1 unknown
trodusquemine sodium-dependent noradrenaline transporter small molecule NA drugbank Obesity[MeSHID:D009765]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of breast[MeSHID:D001943]		 NA investigational unknown
trodusquemine sodium-dependent dopamine transporter small molecule NA drugbank Obesity[MeSHID:D009765]
Diabetes Mellitus
Non-Insulin-Dependent[MeSHID:D003924]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant neoplasm of breast[MeSHID:D001943]		 NA investigational unknown
click here to return to the previous page